Portage Biotech (PRTG)
(Delayed Data from NSDQ)
$9.30 USD
-0.67 (-6.72%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $9.67 +0.37 (3.98%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Portage Biotech Inc. has a market cap of $10.46M, which represents its share price of $9.97 multiplied by its outstanding shares number of 1.05M. As a small-cap company, PRTG's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PRTG 9.30 -0.67(-6.72%)
Will PRTG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PRTG based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PRTG
Portage Biotech Reports Improved Fiscal Year Results
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025 | PRTG Stock News
Portage Biotech Inc. Enters ATM Agreement with Rodman & Renshaw
Why Worthington Steel Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Wednesday's Pre-Market Session